Press Releases
CEA Antibodies Market: Report 2015 and Future Opportunity Assessment 2023

, 20 September 2018 -- CEA Antibodies Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

CEA stands for carcinoembryonic antigen, is a protein that is usually produced in developing fetus and disappears or is absent in ######. Production of abnormal amount of CEA protein may lead to cancer. CEA test is performed to measure the level of proteins and check for the recurrence of colon and other cancers in patients already diagnosed with cancer. The normal accepted range of this protein that is non-cancerous in nature is 0 micrograms to 0.25 micrograms per liter of blood. Elevated levels of carcinoembryonic antigen in patients recently treated for cancer, indicates recurrence of the cancer.

The elevated levels of carcinoembryonic antigens results in different types of cancers and other conditions such as cholecystitis, lung infection, heavy smoking, inflammatory bowel diseases, peptic and ulcer. High level of carcinoembryonic antigens is also found in the patients who are not diagnosed with cancer. This increases the risk of developing cancer in such patients. Hematoma (blood accumulating under the skin), infection, dizziness and excessive bleeding are some of the risks associated with abnormal levels of CEA. The abnormal levels of CEA in the body can be detected by using arcitumomab, a monoclonal antibody. This is commonly utilized in identification of glycoprotein expression in tissue samples. CEA antibody acts against the CEA, and help treat patients with presence of CEA protein. Hence, this antibody in utilized extensively to treat the patients suffering from CEA associated cancers.

Obtain Report Details @

Several drugs (CEA antibody) are currently available in the market that are utilized to treat CEA cancer. Pan CEA and clone II-7 are some of the examples of CEA antibody drugs. Discovery of specific antigens and biomarkers propels the growth of carcinoembryonic antigen antibody market. Similarly, continuous technological advancements in the drugs will also augment the growth of carcinoembryonic antigen antibody market. Likewise, rise in geriatric population also supports the growth of carcinoembryonic antigen antibody market. This is due to the fact that this class of population is at higher risk for developing CEA associated cancers. The World Health of Organization has estimated that by 2050, around 2 billion people belong to this population. However, lack of awareness and availability of novel technological solutions might pose a challenge to the growth of CEA antibody market.

Request Report Brochure @

In 2012, North America accounted for the largest share of the global carcinoembryonic antigen antibody market. This is due to the presence of large number of companies engaged in developing and manufacturing carcinoembryonic antigen antibodies. Also, increasing R&D expenditure by various players in the region will augment the growth of carcinoembryonic antigen antibody market. Likewise, increasing government initiatives regarding the development of carcinoembryonic antigen antibody will further accentuate the growth of carcinoembryonic antigen antibody market. Europe accounted for the second largest share by revenue in 2012 of global carcinoembryonic antigen antibody market.

This large market revenue is attributed to the presence of large geriatric population coupled with increasing healthcare expenditure in the region. Asia-Pacific along with Rest of the World (RoW) contributed smallest share in the global carcinoembryonic antigen antibody market in 2012. Lack of awareness coupled with presence of few pharmaceutical companies that are engaged in developing and manufacturing carcinoembryonic antigen antibodies restrict the growth of carcinoembryonic antigen antibody market in these two regions of the globe.

Request for TOC @

Some of the major players operating in the carcinoembryonic antigen antibody market include Abbott Laboratories, Siemens Healthcare, bioMerieux, Danaher Corporation (Beckman Coulter), Myriad Genetics, Epigenomics, Qiagen N.V., and Life Technologies Corporation among other significant players.

# # #

Submitted by hawer on Thursday, 20 September 2018 at 9:35 PM
Category: Enterprise Technology
Related News

Basis Bay sponsors MDBC’s Innovation & Sustainability Awards 2018
Monday, 17 Jun 2019

Polymath, Blockpass Announce Strategic Collaboration and Partnership
Monday, 17 Jun 2019

Middle East and Africa Cybersecurity Market Outlook 2018-2023
Friday, 14 Jun 2019

Leading Successful Enterprise Outcomes - Solutions Schedule .NET version 8.0
Friday, 14 Jun 2019

Technology Industry Confronts Reputational Challenges from Techlash
Thursday, 13 Jun 2019

Related Events

Security Week 2019
Monday, 17 Jun 2019

Palo Alto Networks: Security Simplified - Enterprise Security Series
Tuesday, 18 Jun 2019

Palo Alto Networks: Speed of Cloud
Wednesday, 19 Jun 2019

Wednesday, 19 Jun 2019

Palo Alto Networks: The Most Advanced Protection for the Cloud
Wednesday, 19 Jun 2019

Latest News

8 Methods to Pick out the very best Yoga Studio for You
Monday, 17 Jun 2019

Bambusparkett – A sustainable alternative to wood flooring
Monday, 17 Jun 2019

Zonnepanelen Plaatsen - De energie van morgen
Monday, 17 Jun 2019

Data Acquisition System Market worth $2.2 billion by 2024
Monday, 17 Jun 2019

Sodium Ascorbate Market Size & Share to See Modest Growth Through 2027
Monday, 17 Jun 2019

Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2019
Today is Monday, 17 June 2019

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Consumer Technology
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
News & Media
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!

Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.

  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.

  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • ISPP 2019 - 12th International Symposium on Pedriatic Pain
  • The Perl Conference, Pittsburgh 2019
  • Predictive Analytics World for Business - Las Vegas - June, 2019
  • Deep Learning World Las Vegas 2019
  • Predictive Analytics World for Industry 4.0 - Las Vegas - June, 2019

  • Latest Jobs
    Sorry, there are currently no entries posted here.